CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Shares withheld for taxes Chief Executive Officer gave up 299,968 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 109,080 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 136,350 shares (to pay taxes)
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Results of operations · Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes Chief Executive Officer gave up 117,633 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 34,442 shares (to pay taxes)
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Other events
Page 9 of 44 · 872 filings